Diamond Therapeutics Inc. is an active federal corporation (corporation number 10955515). Its business number is 739218683. It was incorporated on Aug 21, 2018 under the Canada Business Corporations Act and its registered office is in Toronto, Ontario. The annual return for 2026 is overdue. It has five directors on record.
Corporate details
- Corporation number
- 10955515
- Business number
- 739218683
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Aug 21, 2018
- Registered office
- 100 King Street West, Suite 6200
1 First Canadian Place
Toronto ON M5X 1B8 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Aug 21The date of incorporation, amalgamation or continuance.
- Annual filing period
- Aug 21 to Oct 20 each year
- Last annual meeting
- Not available
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Overdue | |
| 2025 | Filed |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
One agreement since 2023, worth $75,000 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | A feasibility study to determine the potential to develop a low dose solid dose formulation of psilocybin. | $75,000 | Apr 1, 2023 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| Diamond Therapeutics Inc. | Name | Aug 21, 2018 |
Filings and certificates
| What | Date |
|---|---|
| Incorporated | Aug 21, 2018 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.